首页|乳腺癌组织YAP1表达及其与生存的关系

乳腺癌组织YAP1表达及其与生存的关系

扫码查看
目的 转录共激活因子yes相关蛋白1(YAP1)在乳腺癌中的角色一直存在争议,本研究探讨YAP1在浸润性乳腺癌组织中的表达及功能.方法 收集2011-01-01-2013-01-01就诊于青岛大学附属泰安市中心医院的573例浸润性乳腺癌患者完整的临床病理特征和生存数据,免疫组化方法检测YAP1在乳腺癌组织中的表达.x2检验和Spearman相关检验分析YAP1表达与各项临床病理特征的关系,Kaplan-Meier单因素和Cox多因素回归分析YAP1表达水平对不同分子分型乳腺癌患者生存的影响.结果 YAP1主要定位于细胞质和细胞核,在不同的淋巴结状态(x2=7.876,P=0.049)、TNM 分期(x2=8.581,P=0.014)、雌激素受体(x2=6.201,P=0.013)、孕激素受体(x2=4.988,P=0.026)、人表皮生长因子受体 2(x2=4.770,P=0.029)、Ki-67(x2=6.103,P=0.013)和分子分型(x2=17.472,P=0.002)中,YAP1 的表达不同.YAP1 表达与肿瘤大小(ρ=0.111,P=0.008)、淋巴结状态(ρ=0.084,P=0.046)、Ki-67指数(ρ=0.103,P=0.013)和 TNM 分期(ρ=0.122,P=0.003)呈正相关,但与雌激素受体(ρ=-0.104,P=0.013)、孕激素受体(ρ=-0.093,P=0.026)、人表皮生长因子受体 2(ρ=-0.091,P=0.029)和分子亚型(ρ=-0.131,P=0.002)呈负相关.Kaplan-Meier单因素分析显示,肿瘤大小、组织学分级、淋巴结状态、雌激素受体、孕激素受体、Ki-67阳性指数、TNM分期、分子亚型和YAP1表达是影响本研究乳腺癌患者总体人群无病生存期(DFS)和总生存期(OS)的重要因素,P<0.05.在多因素Cox回归分析中,组织学分级、淋巴结状态、孕激素受体和分子亚型是DFS的预后因素(P<0.05),而组织学分级、分子分型和YAP1表达则是OS的预后因素,P<0.05.对不同的分子分型进行具体分析,结果可见在Luminal A型中,YAP1表达对DFS的影响差异有统计学意义(P=0.049),而对OS影响差异无统计学意义;在三阴性亚型中,YAP1对患者的DFS(P=0.022)和OS(P=0.025)影响差异有统计学意义.结论 YAP1在浸润性乳腺癌中作为癌基因发挥作用,可能是判断浸润性乳腺癌尤其是三阴性乳腺癌预后的指标之一.
Expression of YES-associated protein 1 and their relationship with survival in breast cancer tissue
Objective T he function of transcriptional co-activator YES-associated protein 1(YAP1)was controversial in breast cancer.This study aimed to investigate the expression and function of YAP1 in invasive breast cancer tissues.Methods Clinical pathological features and survival data of 573 patients with invasive breast cancer who visited Qingdao University Affiliated Taian Central Hospital from January 1,2011,to January 1,2013,were collected.Immunohisto-chemistry was used to detect the expression of YAP1 in breast cancer tissues.The relationship between YAP1 expression and various clinicopathological features was analyzed using the chi-square test and Spearman's correlation test.Kaplan-Meier univariate analysis and Cox multivariate regression analysis were used to assess the impact of YAP1 expression on the survival of breast cancer patients with different molecular subtypes.Results The study found that YAP1 was mainly localized in the cytoplasm and nucleus.YAP1 expression differed in different lymph node status(x2=7.876,P=0.049),TNM stage(x2=8.581,P=0.014),estrogen receptor(x2=6.201,P=0.013),progesterone receptor(x2=4.988,P=0.026),human epidermal growth factor receptor 2(x2=4.770,P=0.029),Ki-67(x2=6.103,P=0.013),and molecular subtypes(x2=17.472,P=0.002).YAP1 expression was positively correlated with tumor size(ρ=0.111,P=0.008),lymph node status(ρ=0.084,P=0.046),Ki-67 index(ρ=0.103,P=0.013),and TNM stage(ρ=0.122,P=0.003),but negatively correlated with estrogen receptor(ρ=-0.104,P=0.013),progesterone receptor(ρ=-0.093,P=0.026),human epidermal growth factor receptor 2(ρ=-0.091,P=0.029),and molecular subtypes(ρ=-0.131,P=0.002).Kaplan-Meier univariate analysis showed that tumor size,histological grade,lymph node sta-tus,estrogen receptor,progesterone receptor,Ki-67 positive index,TNM stage,molecular subtypes,and YAP1 expres-sion were important factors affecting disease-free survival(DFS)and overall survival(OS)in the overall population of breast cancer patients in this study,P<0.05.In multivariate Cox regression analysis,histological grade,lymph node status,progesterone receptor,and molecular subtypes were significant prognostic factors for DFS(P<0.05),while his-tological grade,molecular subtypes,and YAP1 expression were significant prognostic factors for OS,P<0.05.Specific analysis of different molecular subtypes showed that in Luminal A subtype,the impact of YAP1 expression on DFS was statistically significant(P=0.049),while the impact on OS was not statistically significant.In the triple-negative sub-type,YAP1 had a statistically significant impact on DFS(P=0.022)and OS(P=0.025)of patients.Conclusion YAP1 acts as an oncogene in invasive breast cancer and may be one of the indicators for predicting the prognosis of invasive breast cancer,especially triple-negative subtype.

YES-associated proteinHippo pathwaybreast cancerimmunohistochemistrydisease-free survivaloverall survival

刘志勇、马腾、张亚、刘飞、曹磊、刘婷婷

展开 >

青岛大学附属泰安市中心医院乳腺疾病诊疗中心,山东泰安 271000

山东第一医科大学第二附属医院病理科,山东泰安 271000

yes相关蛋白1 Hippo通路 乳腺癌 免疫组化 无病生存 总生存

泰安市科技创新发展项目泰安市科技创新发展项目

2020NS2812020NS153

2024

社区医学杂志
中华预防医学会

社区医学杂志

影响因子:0.588
ISSN:1672-4208
年,卷(期):2024.22(7)
  • 36